Celanese Faces Pivotal Week with Billion-Dollar Debt Restructuring

The coming days are set to be decisive for shares of chemical specialist Celanese. The catalyst is a major financial maneuver: a billion-dollar debt repurchase initiative designed to reconfigure the company’s balance sheet amid turbulent market conditions.

Despite a challenging operational climate, signals from within the company suggest confidence. Over the past six months, market data records six insider purchases and zero sales by company insiders. One notable transaction involved insider Galante acquiring 2,400 shares for approximately 99,052 USD, indicating internal belief in the equity’s current valuation.

This optimism persists even as the company navigates weak sales. For the third quarter of 2025, Celanese reported Read more...